Phenotypic spectrum of Salla disease, a free sialic acid storage disorder
- PMID: 11992753
- DOI: 10.1016/s0887-8994(01)00406-4
Phenotypic spectrum of Salla disease, a free sialic acid storage disorder
Abstract
Salla disease (MIM 269920) represents the mildest phenotype among recessively inherited lysosomal-free sialic acid storage disorders. Although the vast majority of Salla disease patients in Finland share the same founder mutation, R39C in the SLC17A5 gene, there still is a wide clinical variation among mentally retarded, ataxic patients. We evaluated neurologic and neurocognitive findings of Salla disease in a cross-sectional study of 41 Finnish patients who were 11 months to 63 years of age (median = 19.5 years). The phenotype of Salla disease could be classified into two main categories. The majority of patients (90%) had so-called conventional phenotype, including a subgroup of seven patients with relatively mild symptoms. All but two patients with conventional phenotype were homozygous for the Finnish founder mutation. Four severely disabled, profoundly mentally retarded patients, 15-28 years of age, clearly could be clinically delineated as a separate group, likely reflecting the underlying compound heterozygous genotype. A typical developmental pattern could be outlined in the conventional type of the disease, emphasizing a strong motor handicap in Salla disease. The cognitive profile consisted of better verbal ability, especially speech comprehension, compared with nonverbal functioning in all patients. Our results indicate a partial genotype-phenotype correlation, although factors other than the molecular background are also involved in the phenotypic manifestation of Salla disease.
Similar articles
-
An Italian severe Salla disease variant associated with a SLC17A5 mutation earlier described in infantile sialic acid storage disease.Clin Genet. 2002 Jun;61(6):443-7. doi: 10.1034/j.1399-0004.2002.610608.x. Clin Genet. 2002. PMID: 12121352
-
Neurocognitive profiles in Salla disease.Dev Med Child Neurol. 2004 Dec;46(12):832-7. doi: 10.1017/s0012162204001458. Dev Med Child Neurol. 2004. PMID: 15581157
-
Novel form of intermediate salla disease: clinical and neuroimaging features.J Child Neurol. 2005 Oct;20(10):814-6. doi: 10.1177/08830738050200100601. J Child Neurol. 2005. PMID: 16417876
-
A New Patient With Intermediate Severe Salla Disease With Hypomyelination: A Literature Review for Salla Disease.Pediatr Neurol. 2017 Sep;74:87-91.e2. doi: 10.1016/j.pediatrneurol.2017.05.022. Epub 2017 Jun 1. Pediatr Neurol. 2017. PMID: 28662915 Review.
-
Free sialic acid storage disorder: Progress and promise.Neurosci Lett. 2021 Jun 11;755:135896. doi: 10.1016/j.neulet.2021.135896. Epub 2021 Apr 20. Neurosci Lett. 2021. PMID: 33862140 Free PMC article. Review.
Cited by
-
Diabetes-Associated Mutations in Proinsulin Provide a "Molecular Rheostat" of Nascent Foldability.Curr Diab Rep. 2022 Feb;22(2):85-94. doi: 10.1007/s11892-022-01447-2. Epub 2022 Feb 4. Curr Diab Rep. 2022. PMID: 35119630 Review.
-
Functional characterization of wild-type and mutant human sialin.EMBO J. 2004 Nov 24;23(23):4560-70. doi: 10.1038/sj.emboj.7600464. Epub 2004 Oct 28. EMBO J. 2004. PMID: 15510212 Free PMC article.
-
Prenatal screening of sialic acid storage disease and confirmation in cultured fibroblasts by LC-MS/MS.J Inherit Metab Dis. 2011 Oct;34(5):1069-73. doi: 10.1007/s10545-011-9351-3. Epub 2011 May 27. J Inherit Metab Dis. 2011. PMID: 21617927 Free PMC article.
-
Identification of a large intronic transposal insertion in SLC17A5 causing sialic acid storage disease.Orphanet J Rare Dis. 2017 Feb 10;12(1):28. doi: 10.1186/s13023-017-0584-6. Orphanet J Rare Dis. 2017. PMID: 28187749 Free PMC article.
-
An Unusual Developmental Profile of Salla Disease in a Patient with the SallaFIN Mutation.Case Rep Neurol Med. 2012;2012:615721. doi: 10.1155/2012/615721. Epub 2012 Nov 22. Case Rep Neurol Med. 2012. PMID: 23227378 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources